- As
consumers have become increasingly health conscious as a
fitness-interested segment of society, holistic-oriented wellness products
have gained a parallel footing as alternatives to prescription drugs
- The
trend is exemplified by the recent explosion of interest in cannabis-based
products that don’t have marijuana’s drug qualities but do have muscle
pain and spasm relieving properties
- Neutra
Corp is preparing to introduce a transdermal pain-relief cream based on a
CBD formulation designed to benefit athletes whose workouts induce aches
and pains
- The
CBD market is expected to top $1 billion in sales by 2022, a result of the
growing interest and opportunity surrounding the market
Healthy living solutions research and development
company Neutra Corp (OTCQB: NTRR) is preparing for the market
release of a new transdermal, hemp-based sports cream designed to provide pain
relief for amateur athletes and others involved in activities that require
strenuous performance.
The cream rollout is the latest product to market created
under Neutra’s subsidiary VIVIS Corp., an emerging retail brand of hemp-based
health and nutritional products acquired last month as Neutra’s retail
presence. Vivis has a line of products that feature a 99 percent or higher
grade of hemp-extracted crystalline CBD, and a second product line in the works
will feature an 80 percent or higher grade of full-spectrum CBD extract.
“We’re now seeing the positive payoff of hiring a dedicated
sports medicine advisor earlier this year,” CEO Sydney Jim stated in a news
release about the sports cream development (http://ibn.fm/iazNa). “Our goal with that hire was to
develop hemp-based CBD (cannabidiol) products geared to the expanding sports
market. VIVIS’ upcoming transdermal sports cream will appeal to the rapidly
growing number of active Americans wanting to improve performance, relieve
aches and pains, prevent injuries and lead healthier lifestyles.”
All of Vivis’ CBD products are tested and certified by a
third party to ensure their purity.
Neutra began as a company interested in presenting
all-natural and organic-based products to market in 2011 to help the human
body’s ability to heal and regulate itself. The company has been finding a
niche in the CBD-based market this year, contemplating the industry forecasts
for a rapidly growing billion dollar revenue stream in the United States alone
by 2022 (http://ibn.fm/hzoyi).
“In 2019 we’re really looking at trying to figure out how to
participate in the hemp-based CBD market,” Jim said as part of an interview he
had recently with NetworkNewsAudio (http://ibn.fm/qQbyX). “Our overall goal is to become a
vertically integrated company from cultivation to manufacturing to formulation
of products and then to distribution and retail sales.”
The CBD market is a subset of the cannabis industry, which
has seen an explosion in interest during recent years that has driven
legislative changes and a rebirth of valuation for the plant once common in the
country’s agricultural circles before it was banned as a drug product labeled
as having no practical use.
Hemp-derived CBD, often equated with medical marijuana, has
gained widespread popularity as a home remedy for dealing with muscle pains and
spasms. Neutra cites U.S. Department of Labor statistics indicating some 66
million people across the country are playing some sort of sport or exercising
on any given day, accompanied by Johns Hopkins University research noting most
athletics-caused discomforts can be treated through simple means such as creams
and topicals.
For more information, visit the company’s website at www.NeutraInc.com
NOTE TO INVESTORS: The latest news and updates
relating to NTRR are available in the company’s newsroom at http://ibn.fm/NTRR
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment